<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Sulfasalazine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00795</strong>&#160; (APRD00152, DB08518)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see mesalamine) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00795/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00795/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00795.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00795.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00795.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00795.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00795.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00795">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Azopyrin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>IS</td></tr><tr><td>Salazosulfapyridine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>JAN</td></tr><tr><td>Sulfasalazin</td><td>German</td><td>INN</td></tr><tr><td>Sulfasalazina </td><td>Spanish</td><td>INN</td></tr><tr><td>Sulfasalazine</td><td>French</td><td>INN</td></tr><tr><td>Sulfasalazinum</td><td>Latin</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Asasurfan</td><td>Choseido Pharmaceutical</td></tr><tr><td>Azulfdidina</td><td>Pfizer</td></tr><tr><td>Azulfidine</td><td>Pfizer</td></tr><tr><td>Azulfin</td><td>Apsen</td></tr><tr><td>Bomecon</td><td>Fu Seng</td></tr><tr><td>Colo-Pleon</td><td>Sanofi-Aventis</td></tr><tr><td>Disalazin</td><td>AC Farma</td></tr><tr><td>Eminapyrin</td><td>Taiyo Pharmaceutical</td></tr><tr><td>Flogostop</td><td>Ivax</td></tr><tr><td>Iwata</td><td>Cadila</td></tr><tr><td>Lanofen</td><td>Taisho Yakuhin</td></tr><tr><td>Lazafin</td><td>Novell</td></tr><tr><td>Pleon</td><td>Sanofi-Aventis</td></tr><tr><td>Pyralin EN</td><td>Pfizer</td></tr><tr><td>Reumazin</td><td>Aristopharma</td></tr><tr><td>Saaz</td><td>Ipca</td></tr><tr><td>Saaz-DS</td><td>Ipca</td></tr><tr><td>Salasopyrine</td><td>Upjohn</td></tr><tr><td>Salazar</td><td>Cadila</td></tr><tr><td>Salazidin</td><td>Helcor</td></tr><tr><td>Salazine</td><td>Opsonin</td></tr><tr><td>Salazopirina</td><td>Jaba Recordati</td></tr><tr><td>Salazoprin</td><td>Cazi</td></tr><tr><td>Salazopyrin</td><td>Pfizer</td></tr><tr><td>Salazopyrin EN</td><td>Pfizer</td></tr><tr><td>Salazopyrin EN-Tabs</td><td>Pharmacia</td></tr><tr><td>Sulcolon</td><td>Bernofarm</td></tr><tr><td>Sulfacol</td><td>Drug International</td></tr><tr><td>Weiliufen</td><td>Sunve</td></tr><tr><td>Zopyrin</td><td>Han Lim</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/antirheumatic-agents">Antirheumatic Agents</a></li>
<li><a href="/mesh/anti-inflammatory-agents-non-steroidal">Anti-Inflammatory Agents, Non-Steroidal</a></li>
<li><a href="/mesh/gastrointestinal-agents">Gastrointestinal Agents</a></li>
<li><a href="/mesh/anti-infective-agents">Anti-Infective Agents</a></li>
<li><a href="/mesh/sulfonamides">Sulfonamides</a></li></ul></td></tr><tr><th>CAS number</th><td>599-79-1</td></tr><tr><th>Weight</th><td>Average: 398.393<br>Monoisotopic: 398.068490268</td></tr><tr><th>Chemical Formula</th><td>C<sub>18</sub>H<sub>14</sub>N<sub>4</sub>O<sub>5</sub>S</td></tr><tr><th>InChI Key</th><td>NCEXYHBECQHGNR-QZQOTICOSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">2-hydroxy-5-[(E)-2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}diazen-1-yl]benzoic acid</div></td></tr><tr><th>SMILES</th><td><div class="wrap">OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Benzenoids</td></tr><tr><th>Class</th><td>Benzene and Substituted Derivatives</td></tr><tr><th>Subclass</th><td>Benzenesulfonamides</td></tr><tr><th>Direct parent</th><td>Aminobenzenesulfonamides</td></tr><tr><th>Alternative parents</th><td>Aminobenzoic Acid Derivatives; Salicylic Acids; Benzoic Acids; Aminophenols; Benzoyl Derivatives; Aminopyridines and Derivatives; Sulfonyls; Sulfonamides; Azo Compounds; Enolates; Polyamines; Enols; Carboxylic Acids</td></tr><tr><th>Substituents</th><td>benzoic acid; benzoic acid or derivative; benzoyl; aminophenol; aminopyridine; phenol derivative; pyridine; sulfonyl; sulfonamide; sulfonic acid derivative; azo compound; enol; carboxylic acid derivative; enolate; carboxylic acid; polyamine; amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of Crohn's disease and rheumatoid arthritis as a second-line agent.</td></tr><tr><th>Pharmacodynamics</th><td>Sulfasalazine is an anti-inflammatory indicated for the treatment of ulcerative colitis and rheumatoid arthritis.</td></tr><tr><th>Mechanism of action</th><td>The mode of action of Sulfasalazine or its metabolites, 5-aminosalicylic acid (5-ASA) and sulfapyridine (SP), is still under investigation, but may be related to the anti-inflammatory and/or immunomodulatory properties that have been observed in animal and <i>in vitro</i> models, to its affinity for connective tissue, and/or to the relatively high concentration it reaches in serous fluids, the liver and intestinal walls, as demonstrated in autoradiographic studies in animals. In ulcerative colitis, clinical studies utilizing rectal administration of Sulfasalazine, SP and 5-ASA have indicated that the major therapeutic action may reside in the 5-ASA moiety. The relative contribution of the parent drug and the major metabolites in rheumatoid arthritis is unknown.</td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><ul>
	<li>7.5 &#177; 1.6 L</li>
</ul></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td>The majority of 5-ASA stays within the colonic lumen and is excreted as 5-ASA and acetyl-5-ASA with the feces.</td></tr><tr><th>Half life</th><td>5-10 hours</td></tr><tr><th>Clearance</th><td><ul>
	<li>1 L/h [IV administration]</li>
</ul></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9156</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.7294</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.6893</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.8405</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9096</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.853</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8956</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.6445</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.7557</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9046</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Inhibitor</td>
        <td>0.8948</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9231</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.923</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8309</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.8895</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9133
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.6468
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9472
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          1.4383 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.939
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.821
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Pharmacia and upjohn co</li>
<li>Vintage pharmaceuticals inc</li>
<li>Watson laboratories inc</li>
<li>Solvay pharmaceuticals</li>
<li>Heritage pharmaceuticals inc</li>
<li>Mutual pharmaceutical co inc</li>
<li>Sandoz inc</li>
<li>Superpharm corp</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li>Carlisle Laboratories Inc.</li>
<li><a href="http://www.darbydental.com">Darby Dental Supply Co. Inc.</a></li>
<li>Direct Dispensing Inc.</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.greenstonellc.com">Greenstone LLC</a></li>
<li>Kaiser Foundation Hospital</li>
<li><a href="http://www.kemwellpharma.com">Kemwell AB</a></li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li>Mutual Pharmaceutical Co.</li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li><a href="http://www.patheon.com">Patheon Inc.</a></li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li><a href="http://www.pfizer.com">Pfizer Inc.</a></li>
<li><a href="http://www.pharmaciaupjohn.com">Pharmacia Inc.</a></li>
<li><a href="http://www.pharmedixrx.com">Pharmedix</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.prepaksys.com">Prepak Systems Inc.</a></li>
<li><a href="http://www.worldoftest.com">Qualitest</a></li>
<li><a href="http://www.remedyrepack.com">Remedy Repack</a></li>
<li>Tya Pharmaceuticals</li>
<li><a href="http://www.urlpharma.com">United Research Laboratories Inc.</a></li>
<li>Vintage Pharmaceuticals Inc.</li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Tablet</td><td>Oral</td><td></td></tr><tr><td>Tablet, coated</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00993">Azathioprine</a></td><td>Sulfasalazine may increase the toxicity of thiopurine, azathioprine.</td></tr><tr><td><a href="/drugs/DB08822">Azilsartan medoxomil</a></td><td>Increases toxicity of each. May deteriorate renal function, particularly in volume depleted or elderly patients. Decreases effects of azilsartan by antagonism. </td></tr><tr><td><a href="/drugs/DB00672">Chlorpropamide</a></td><td>Sulfonamide/sulfonylurea: possible hypoglycemia</td></tr><tr><td><a href="/drugs/DB00091">Cyclosporine</a></td><td>The sulfonamide decreases the effect of cyclosporine</td></tr><tr><td><a href="/drugs/DB00390">Digoxin</a></td><td>Sulfasalazine may decrease the effect of digoxin.</td></tr><tr><td><a href="/drugs/DB01033">Mercaptopurine</a></td><td>Sulfasalazine may increase the toxicity of thiopurine, mercaptopurine.</td></tr><tr><td><a href="/drugs/DB00352">Tioguanine</a></td><td>Sulfasalazine may increase the toxicity of thiopurine, thioguanine.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>May take Vitamin D.</li>
<li>Take with a full glass of water No iron, zinc or fluoride within 2 hours of taking this medication.</li>
<li>Take with food.</li></ul></td></tr></tbody></table>